Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Financing Healthy Living

Related Content

Equity on Ice: A Solution for the Repurchase Conundrum

Which Jobs More Frequently Require Non-Compete Agreements?

FinCEN Proposed the Renewal of its Existing Information Collection Requirements Previously Promulgated Under the BSA

FTC Issues Final Rule Prohibiting Most Post-Employment Non-Compete Agreements

European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy

Healthcare M&A and Financing Trends and Predictions for 2024

Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference (Westlaw Today)

CFPB Updates Supervision Designation Procedures

What Tech Companies Need to Know: State of Tech M&A Panel

BridgeBio Oncology Therapeutics Completes $200 Million Private Financing

Goodwin Bolsters Leading Life Sciences Practice with Partner Michael Siekman in Boston

Townsend Holdings Sold to Riverside

Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion

Digital Markets Guide: US Skepticism of Tech Transactions Sparks a Step-Up in Merger Enforcement (GCR)

Alpine Immune Sciences To Be Acquired by Vertex Pharmaceuticals For $4.9 Billion

Auradine Raises $80 Million in Series B Financing and Achieves $80 Million in Bookings

Technology

Private Equity

Mergers & Acquisitions

Capital Markets